Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-26

FDA Approved: TELMISARTAN — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic telmisartan product submitted by Solco Healthcare US, LLC. Telmisartan is used to treat hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)